Interim Director:

Matthew D. Ringel, MD 


Interim Director, The Center for Clinical and Translational Science 

Dr. Matthew Ringel

Principal Investigator for the National Institutes of Health Clinical and Translational Science Awards (NIH-CTSA) grant

Matthew D. Ringel, MD is the director of the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University College of Medicine, co-leader of the Cancer Biology Program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the interim director for The Ohio State University Center for Clinical and Translational Science (CCTS). Dr, Ringel also holds the Ralph W. Kurtz Chair in Hormonology and is an internationally recognized thyroid cancer expert and Principal Investigator (PI) of the Ringel Lab at the OSUCCC – James.  

Dr. Ringel graduated from Penn State University College of Medicine in 1991 and completed his residency at MedStar Georgetown University Hospital and his Fellowship in Endocrinology, Diabetes and Metabolism at Johns Hopkins Hospital. Dr. Ringel specializes in thyroid cancer and research focusing on molecular mechanisms involved in thyroid cancer invasion and metastasis, with a specialized interest in thyroid cancer therapy. 

In addition, Dr. Ringel serves as PI for two National Cancer Institute (NCI) grant-funded studies, both of which center around translational research on thyroid cancer. He previously served as PI for two NCI-funded grants, one to study genetic and signaling pathways in epithelial thyroid cancer and the other, a Specialized Program of Research Excellence (SPORE) grant to help improve the lives of patients with thyroid cancer.  

During his tenure Dr. Ringel authored and co-authored more than 150 papers in numerous scientific journals and has been the recipient of many awards, including the Sidney H. Ingbar Distinguished Lectureship Award, an honor that recognizes outstanding academic achievements in thyroid-related research. He is also an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. 


Pediatric Director:

Bill Smoyer, MD

William E. Smoyer, MD

Vice President for Clinical and Translational Research at NCH

Director of the Center for Clinical and Translational Research at NCH

The Research Institute at Nationwide Children's Hospital

700 Children's Drive

Columbus, OH 43205

Phone: 614-722-2683


Dr. Smoyer’s career has focused on basic, clinical and translational research to improve our understanding of the molecular regulation of podocyte injury during nephrotic syndrome, and to develop more targeted and effective novel treatments for childhood nephrotic syndrome. 

His work has led to publications in the Journal of Clinical Investigation, FASEB, the Journal of the American Society of Nephrology, as well as several subspecialty journals. 

Dr. Smoyer oversees clinical and translational research initiatives by pediatric researchers and seeks opportunities to integrate pediatrics into all CCTS activities, including education, informatics, translational technologies, research design and implementation programs and resource allocation. Under his leadership, NCH has expanded its strategic prioritization of clinical and translational research over the last decade, including an extensive array of core services to fully support clinical research at Nationwide Children’s Hospital and The Ohio State University. 


Founding Director and PI, Dr. Rebecca Jackson, 2006 – 2022 

Dr. Rebecca Jackson

Dr. Jackson was a visionary and nationally recognized leader in the world of translational science and research. She helped establish the CCTS in 2006 as its founding director and served through 2022. While her clinical work specialized in understanding and improving women’s health, she built a legacy that lives on through her impact as a leader. She supported the education and training of translational scientists and physicians and served as a mentor to many. Dr. Jackson’s work will forever leave a profound impact for the future of medicine. 

(August 18, 1955 - October 11, 2022)

Read more about Dr. Jackson on Ohio State News